Sunshine Biopharma (SBFM) Share-based Compensation (2010 - 2024)

Sunshine Biopharma (SBFM) posted Share-based Compensation of $12000.0 for Q1 2024, down 98.69% on a QoQ basis from $918000.0 in Q1 2021.

Sunshine Biopharma (SBFM) Share-based Compensation (2010 - 2024) Analysis & Trends

Sunshine Biopharma's Share-based Compensation history runs 13 years deep, the most recent figure standing at $12000.0 for Q1 2024.

Quarterly Share-based Compensation changed N/A year-over-year to $12000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $12000.0 (changed N/A YoY) and the FY2024 annual result came in at $12000.0, changed N/A from the prior year.
Share-based Compensation was $12000.0 for Q1 2024 at Sunshine Biopharma, down from $918000.0 in the prior quarter.
Across five years, Share-based Compensation topped out at $918000.0 in Q1 2021 and bottomed at $12000.0 in Q1 2024.
A 3-year average of $326666.7 and a median of $50000.0 in 2020 frame the typical range for Share-based Compensation.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Haleon	89.28 Bn	87.42 Bn	-	-
2	Teva Pharmaceutical Industries	35.97 Bn	32.23 Bn	1.97 Bn	43.00 Mn
3	Zoetis	32.42 Bn	30.48 Bn	1.62 Bn	25.00 Mn
4	Takeda Pharmaceutical	27.48 Bn	23.42 Bn	4.39 Bn	125.69 Mn
5	United Therapeutics	22.89 Bn	20.73 Bn	648.10 Mn	58.30 Mn
6	RedHill Biopharma	22.11 Bn	22.11 Bn	-	-
7	Viatris	20.44 Bn	18.64 Bn	1.16 Bn	56.50 Mn
8	Neurocrine Biosciences	17.76 Bn	16.44 Bn	800.70 Mn	55.70 Mn
9	Elanco Animal Health	12.62 Bn	12.19 Bn	785.00 Mn	21.00 Mn
10	Sunshine Biopharma	750,608.81	-6.16 Mn	2.18 Mn	-

Download Data